Sisram Medical Announces Board and CEO Changes Effective January 2026

Reuters12-08
Sisram Medical Announces Board and CEO Changes Effective January 2026

Sisram Medical Ltd. has announced changes to its management and board, effective January 1, 2026. Yi Liu, Lior Moshe Dayan, and Jiahong Li serve as executive directors, while Yifang Wu and Rongli Feng are non-executive directors. The board also includes Heung Sang Addy Fong, Chi Fung Leo Chan, Jenny Chen, and Kai Yu Kenneth Liu as independent non-executive directors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251208-11948580), on December 08, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment